Orionis Biosciences has announced a multi-year partnership with Roche’s Genentech, focusing on the discovery and development of small-molecule monovalent glue medicines for difficult targets in ...

Its brightest stars — Betelgeuse (Alpha [α] Orionis) and Rigel (Beta [β] Orionis ... Next month, we’ll head south for a late winter getaway. Questions, comments, suggestions are always ...

Roche has bolstered its R&D pipeline in oncology and neuroscience with a pair of partnerships with Orionis Biosciences and PeptiDream, parting with upfront cash of $87 million for projects in the ...

Captured by the Hubble Space Telescope, the heliosphere of a young star, LL Orionis, collides with an interstellar medium of dust. A similar event with our own sun, researchers say, might have ...

Orionis Biosciences, a privately held company, announced a second multi-year collaboration with Genentech, a member of the Roche Group (OTCQX:RHHBY) on Wednesday. The goal of this partnership is ...

BOSTON & GHENT, Belgium--(BUSINESS WIRE)--Orionis Biosciences, a life sciences company pioneering innovation of highly selective and tunable therapeutics for cancer and beyond, today presented ...

BOSTON & GHENT, Belgium--(BUSINESS WIRE)--Orionis Biosciences, a life sciences company pioneering the creation of highly selective and tunable therapeutics for cancer and other diseases ...

A star about 1,360 light-years away from Earth, named FU Orionis, is twice as hot as astronomers previously suspected, according to recent data from the Hubble Space Telescope. In fact ...

Roche's Genentech is sticking with Orionis Biosciences, handing over $105 million upfront as part of its second deal with the molecular glue biotech. The latest multiyear collaboration will be ...